Cart
sales@molnova.com
Trimebutine CTB salt
CAS No. 1456509-46-8
Trimebutine CTB salt( —— )
Catalog No. M34266 CAS No. 1456509-46-8
Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2403 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTrimebutine CTB salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
-
DescriptionTrimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1456509-46-8
-
Formula Weight604.74
-
Molecular FormulaC29H36N2O8S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCC(C=1C=CC=CC1)(N(C)C)CC)C2=CC(OC)=C(OC)C(OC)=C2.O=S(=O)(O)C=1C=CC=C(C1)C(=S)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
β-Casomorphin, bovin...
β-Casomorphin, bovine TFA is an opioid peptide isolated from casein peptoneβ-Casomorphin, bovine(beta-casomorphin-7) may contribute significantly to mucin production via a direct effect on intestinal goblet cells and the activation of mu-opioid receptors.?
-
BTRX-335140
BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
-
FDI-6
FDI-6 is an effective and selective inhibitor of FOXM1 that blocks DNA binding. FDI-6 binds to the FOXM1 protein and specifically downregulates FOXM1-activated genes.
